GYRE

GYRE Total Assets

$199.26MQuarterly · USD

Period ending:

GYRE FY Total AssetsUSD
GYRE FY Total Assets2001-12-31: $24.40M2002-12-31: $54.38M2003-12-31: $47.39M2004-12-31: $58.20M2005-12-31: $28.00M2006-12-31: $81.37M2007-12-31: $98.96M2008-12-31: $98.55M2009-12-31: $319.38M2010-12-31: $262.79M2011-12-31: $258.13M2012-12-31: $189.58M2013-12-31: $145.87M2014-12-31: $112.00M2015-12-31: $69.52M2016-12-31: $38.09M2017-12-31: $39.51M2018-12-31: $124.92M2019-12-31: $98.55M2020-12-31: $94.85M2021-12-31: $55.66M2022-12-31: $84.75M2023-12-31: $116.54M2024-12-31: $125.41M2025-12-31: $166.13M$319.38M$0.00
2001-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

GYRE total assets history

Total value of everything the company owns. The available annual fiscal periods series contains 25 observations from Dec 31, 2001 to Dec 31, 2025.

Gyre Therapeutics Inc Total Assets — Annual fiscal periods (USD)
Period endingTotal Assets (USD)
166,132,000
125,406,000
116,539,000
84,753,000
55,662,000
94,846,000
98,554,000
124,920,000
39,513,000
38,090,000
69,521,000
111,999,000
145,873,000
189,579,000
258,126,000
262,787,000
319,379,000
98,551,000
98,964,995
81,368,470
28,001,143
58,203,824
47,390,000
54,379,000
24,396,000

Compare total assets

All GYRE financial metrics · GYRE stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.